| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UKNOWN |
| UNII: | OG837L732J |
Structure
| InChI Key | NBMBIEOUVBHEBM-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C23H23N5O2 |
| Molecular Weight | 401.47 |
| AlogP | 2.85 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 73.02 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 30.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
|
- | - | - | 0-1 | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Anxiety | 2 | D001007 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL513922 |
| DrugBank | DB12666 |
| EPA CompTox | DTXSID40177220 |
| FDA SRS | OG837L732J |
| Guide to Pharmacology | 8704 |
| SureChEMBL | SCHEMBL4757030 |
| ZINC | ZINC000000602486 |
CONTENTS